blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2768486

EP2768486 - TOCOTRIENOL COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.08.2019
Database last updated on 17.07.2024
FormerThe patent has been granted
Status updated on  31.08.2018
FormerGrant of patent is intended
Status updated on  02.04.2018
FormerExamination is in progress
Status updated on  08.12.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK
published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
First Tech International Limited
Villa 151 Beijing Eurovillage
8 Yu Yang Yu
Tianzhu Town, Beijing 101300 / CN
[2018/40]
Former [2014/35]For all designated states
First Tech International Limited
Villia 151 Beijing Eurovillage
8 Yu Yang Yu
Tianzhu Town, Beijing 101300 / CN
Inventor(s)01 / NAZZAL, Sami
3111 Old Sterlington Road 156
Monroe, LA 71203 / US
02 / SYLVESTER, Paul
205 Andre Drive
West Monroe, LA 71291 / US
03 / ALAYOUBI, Alaadin
510 Warhawk way, Apt 45
Monroe, LA 71203 / US
 [2014/35]
Representative(s)Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2018/40]Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2014/35]Andrews, Paul David
Muritroyd & Company 165-169 Scotland Street
Glasgow, Strathclyde G5 8PL / GB
Application number, filing date12841429.919.10.2012
[2018/40]
WO2012US61198
Priority number, dateUS201161550009P21.10.2011         Original published format: US 201161550009 P
US201261667489P03.07.2012         Original published format: US 201261667489 P
[2014/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013059729
Date:25.04.2013
Language:EN
[2013/17]
Type: A1 Application with search report 
No.:EP2768486
Date:27.08.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 25.04.2013 takes the place of the publication of the European patent application.
[2014/35]
Type: B1 Patent specification 
No.:EP2768486
Date:03.10.2018
Language:EN
[2018/40]
Search report(s)International search report - published on:US25.04.2013
(Supplementary) European search report - dispatched on:EP08.04.2015
ClassificationIPC:A61K9/107
[2015/19]
CPC:
A61K31/355 (EP); A61K9/1075 (EP); A61P35/00 (EP)
Former IPC [2014/35]A61K9/16
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/35]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:TOCOTRIENOLZUSAMMENSETZUNGEN[2014/35]
English:TOCOTRIENOL COMPOSITIONS[2014/35]
French:COMPOSITIONS DE TOCOTRIÉNOL[2014/35]
Entry into regional phase13.05.2014National basic fee paid 
13.05.2014Search fee paid 
13.05.2014Designation fee(s) paid 
13.05.2014Examination fee paid 
Examination procedure13.05.2014Examination requested  [2014/35]
26.10.2015Amendment by applicant (claims and/or description)
12.12.2017Despatch of a communication from the examining division (Time limit: M02)
05.02.2018Reply to a communication from the examining division
03.04.2018Communication of intention to grant the patent
19.07.2018Fee for grant paid
19.07.2018Fee for publishing/printing paid
19.07.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.12.2017
Opposition(s)04.07.2019No opposition filed within time limit [2019/37]
Fees paidRenewal fee
31.10.2014Renewal fee patent year 03
30.10.2015Renewal fee patent year 04
27.10.2016Renewal fee patent year 05
30.10.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.10.2012
AL03.10.2018
AT03.10.2018
CY03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
MK03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
IE19.10.2018
LU19.10.2018
MT19.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
[2020/31]
Former [2020/30]HU19.10.2012
AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
IE19.10.2018
LU19.10.2018
MT19.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2020/17]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
IE19.10.2018
LU19.10.2018
MT19.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2020/08]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
IE19.10.2018
LU19.10.2018
MT19.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/50]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
IE19.10.2018
LU19.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/48]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SK03.10.2018
SM03.10.2018
IE19.10.2018
LU19.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/40]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SK03.10.2018
SM03.10.2018
LU19.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/38]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SM03.10.2018
LU19.10.2018
BE31.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/37]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
NL03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SE03.10.2018
SM03.10.2018
LU19.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/34]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
IT03.10.2018
LT03.10.2018
LV03.10.2018
NL03.10.2018
PL03.10.2018
RS03.10.2018
SE03.10.2018
LU19.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/30]AL03.10.2018
AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
NL03.10.2018
PL03.10.2018
RS03.10.2018
SE03.10.2018
LU19.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/26]AL03.10.2018
AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
NL03.10.2018
PL03.10.2018
RS03.10.2018
SE03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/25]AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
NL03.10.2018
PL03.10.2018
RS03.10.2018
SE03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/24]AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
NL03.10.2018
PL03.10.2018
SE03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/23]AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
NL03.10.2018
PL03.10.2018
BG03.01.2019
NO03.01.2019
IS03.02.2019
Former [2019/22]CZ03.10.2018
FI03.10.2018
LT03.10.2018
NL03.10.2018
PL03.10.2018
BG03.01.2019
NO03.01.2019
IS03.02.2019
Former [2019/21]FI03.10.2018
LT03.10.2018
NL03.10.2018
NO03.01.2019
IS03.02.2019
Former [2019/20]LT03.10.2018
NL03.10.2018
NO03.01.2019
Former [2019/17]NL03.10.2018
Documents cited:Search[X]WO9703651  (DANBIOSYST UK [GB], et al) [X] 1-8 * example 9 * * table 3 * * claims 1,2 *;
 [X]EP1170003  (HOVID SDN BHD [MY]) [X] 1-8 * paragraphs [0012] , [0019] - [0021] * * claims 1-8,13 *;
 [X]WO0226324  (SONUS PHARMA INC [US], et al) [X] 1-8 * example 9 *;
 [X]US2006014788  (GUMKOWSKI MICHAEL J [US], et al) [X] 1-8 * tables 10a,12a *;
 [X]US2011045050  (ELBAYOUMI TAMER A [US], et al) [X] 1-8 * paragraphs [0052] , [0062] , [0083] * * example 3 * * claims 1,10-12,22,34,39 *;
 [A]  - JULIANTO T ET AL, "IMPROVED BIOAVAILABILITY OF VITAMIN E WITH A SELF EMULSIFYING FORMULATION", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, (20000101), vol. 200, no. 1, doi:10.1016/S0378-5173(00)00337-9, ISSN 0378-5173, pages 53 - 57, XP001030779 [A] 1-8 * page 54, column 1, paragraph 4 * * page 57, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0378-5173(00)00337-9
International search[Y]US2004043043  (SCHLYTER JIMMY HIRSCHSPRUNG [DK], et al);
 [Y]US2010166918  (MILLER RAYMOND A [US]);
 [Y]US2010292316  (SANDERS BOB G [US], et al);
 [Y]US2011052704  (NAZZAL SAMI MAHMOUD [US], et al);
 [A]  - TANG ET AL., "Self-Emulsifying Drug Delivery Systems: Strategy for Improving Oral Delivery of Poorly Soluble Drugs", CURRENT DRUG THERAPY, (2007), vol. 2, pages 85 - 93, XP055066285

DOI:   http://dx.doi.org/10.2174/157488507779422400
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.